ZA937244B - Use of IL-10 to prevent or treat insulin-dependentdiabetes mellitus - Google Patents

Use of IL-10 to prevent or treat insulin-dependentdiabetes mellitus

Info

Publication number
ZA937244B
ZA937244B ZA937244A ZA937244A ZA937244B ZA 937244 B ZA937244 B ZA 937244B ZA 937244 A ZA937244 A ZA 937244A ZA 937244 A ZA937244 A ZA 937244A ZA 937244 B ZA937244 B ZA 937244B
Authority
ZA
South Africa
Prior art keywords
prevent
treat insulin
mellitus
dependentdiabetes
dependentdiabetes mellitus
Prior art date
Application number
ZA937244A
Other languages
English (en)
Inventor
Martha W Bond
Kevin W Moore
Kenneth Pennline
Paulo J M Vieira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA937244B publication Critical patent/ZA937244B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA937244A 1992-10-01 1993-09-29 Use of IL-10 to prevent or treat insulin-dependentdiabetes mellitus ZA937244B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95552392A 1992-10-01 1992-10-01

Publications (1)

Publication Number Publication Date
ZA937244B true ZA937244B (en) 1994-06-27

Family

ID=25496932

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937244A ZA937244B (en) 1992-10-01 1993-09-29 Use of IL-10 to prevent or treat insulin-dependentdiabetes mellitus

Country Status (24)

Country Link
EP (1) EP0662837B1 (xx)
JP (1) JP2739770B2 (xx)
KR (1) KR0166663B1 (xx)
CN (1) CN1093598A (xx)
AT (1) ATE180168T1 (xx)
AU (1) AU689448B2 (xx)
CA (1) CA2145863A1 (xx)
CZ (1) CZ286866B6 (xx)
DE (1) DE69325029T2 (xx)
DK (1) DK0662837T3 (xx)
ES (1) ES2131122T3 (xx)
FI (1) FI951511A (xx)
GR (1) GR3030269T3 (xx)
HK (1) HK1008812A1 (xx)
HU (1) HU217871B (xx)
IL (1) IL107153A (xx)
MX (1) MX9306043A (xx)
MY (1) MY111543A (xx)
NO (1) NO951240L (xx)
SG (1) SG48733A1 (xx)
SK (1) SK281806B6 (xx)
TW (1) TW336172B (xx)
WO (1) WO1994008606A1 (xx)
ZA (1) ZA937244B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995027500A1 (en) * 1994-04-08 1995-10-19 Brigham And Women's Hospital TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
EP1621206A1 (en) * 1994-12-12 2006-02-01 Beth Israel Deaconess Medical Center, Inc. Chimeric cytokines and uses thereof
CA2228620A1 (en) * 1995-08-07 1997-02-20 John E. Oakes Treatment of ocular inflammatory conditions with interleukin-10
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
WO1997005896A1 (en) * 1995-08-09 1997-02-20 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US5939069A (en) * 1996-08-23 1999-08-17 University Of Florida Materials and methods for detection and treatment of immune system dysfunctions
US6171856B1 (en) 1997-07-30 2001-01-09 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
AU8671798A (en) * 1997-07-30 1999-02-22 Betagene, Inc. Methods and compositions relating to no-mediated cytotoxicity
CA2306811A1 (en) * 1997-10-14 1999-04-22 Yoshiyuki Aoki Piperazine compounds and medicinal use thereof
JP2002289768A (ja) 2000-07-17 2002-10-04 Rohm Co Ltd 半導体装置およびその製法
CN100515491C (zh) * 2005-01-04 2009-07-22 健能隆医药技术（上海）有限公司 白介素-22的医药用途
WO2014098249A1 (ja) 2012-12-21 2014-06-26 国立大学法人名古屋大学 組織修復活性組成物及びその利用
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
WO2017181143A1 (en) 2016-04-15 2017-10-19 Generon (Shanghai) Corporation, Ltd. Use of il-22 in treating necrotizing enterocolitis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
CN1093598A (zh) 1994-10-19
WO1994008606A1 (en) 1994-04-28
CZ80495A3 (en) 1996-01-17
AU5163593A (en) 1994-05-09
ATE180168T1 (de) 1999-06-15
DE69325029D1 (de) 1999-06-24
FI951511A0 (fi) 1995-03-30
GR3030269T3 (en) 1999-08-31
ES2131122T3 (es) 1999-07-16
DE69325029T2 (de) 1999-10-07
HU217871B (hu) 2000-04-28
SK42395A3 (en) 1997-01-08
HU9500933D0 (en) 1995-05-29
CZ286866B6 (en) 2000-07-12
SG48733A1 (en) 1998-05-18
KR0166663B1 (en) 1999-01-15
EP0662837A1 (en) 1995-07-19
TW336172B (en) 1998-07-11
SK281806B6 (sk) 2001-08-06
NO951240D0 (no) 1995-03-30
KR950703353A (ko) 1995-09-20
HUT71421A (en) 1995-11-28
DK0662837T3 (da) 1999-11-08
AU689448B2 (en) 1998-04-02
JPH07507567A (ja) 1995-08-24
FI951511A (fi) 1995-03-30
NO951240L (no) 1995-05-30
JP2739770B2 (ja) 1998-04-15
CA2145863A1 (en) 1994-04-28
HK1008812A1 (en) 1999-05-21
MY111543A (en) 2000-08-30
MX9306043A (es) 1994-04-29
EP0662837B1 (en) 1999-05-19
IL107153A0 (en) 1993-12-28
IL107153A (en) 2000-07-16

Similar Documents

Publication Publication Date Title
EP0686203A4 (en) COMPOUNDS AND METHODS RELATING TO THE DIAGNOSIS, TREATMENT AND PREVENTION OF CELL DEATH DISEASES
MY111543A (en) Use of il-10 to prevent or treat insulin-dependent diabetes mellitus
AU7545594A (en) Implantable device for the treatment of aedemas
AU8163394A (en) Treatment of diabetes by administration of myo-inositol
AU4714393A (en) Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity
EP0594410A3 (en) Treatment of rubber articles.
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
AU4376396A (en) Use of andrographolide compounds to treat or prevent pathogenicity of diseases
GB9323808D0 (en) Composition containing zinc for the treatment of skin disorders
AU3730093A (en) Methods of treating diabetes
EP0674707A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF LEUCOMA.
ZA931063B (en) Treatment of glaucoma.
HU9502623D0 (en) Use of substituted alkyl-nitrates for the treatment of pathologically increased intraocular pressure
AU8927191A (en) Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen
IL105285A0 (en) Compositions for the treatment of diabetes
AU7719491A (en) Therapeutic compound
IL106064A0 (en) Gallium complexes for the treatment of free radicalinduced diseases
ES8507552A1 (es) Un procedimiento para preparar 6-metilsulfonil-espiro-(croman-4,4'-imidazolidin)-2',5'-diona
ZA931062B (en) Compositions for the treatment of glaucoma.
AU8488591A (en) Apparatus for treatment of vegetation
AU7850491A (en) Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen
BG98003U (en) Medicament for the treatment of dermatomycosis
AU7377491A (en) Dr M and Zenni method of treatment by electro-stimulations of the central nervous system
BG98002U (en) Medicament for the treatment of seborrheic conditions
IE880151L (en) Method for treatment of hyperacidity.